相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Colorectal cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 Study
Kai-Keen Shiu et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The human tumor microbiome is composed of tumor type-specific intracellular bacteria
Deborah Nejman et al.
SCIENCE (2020)
Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline
E. Gabriela Chiorean et al.
JCO GLOBAL ONCOLOGY (2020)
Selected Aspects of Chemoresistance Mechanisms in Colorectal CarcinomaA Focus on Epithelial-to-Mesenchymal Transition, Autophagy, and Apoptosis
Veronika Skarkova et al.
CELLS (2019)
Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer
Andre F. Oliveira et al.
FRONTIERS IN ONCOLOGY (2019)
Gut microbiota in colorectal cancer: mechanisms of action and clinical applications
Sunny H. Wong et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer
Sheng Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
AJCC 8th Edition: Colorectal Cancer
Martin R. Weiser
ANNALS OF SURGICAL ONCOLOGY (2018)
Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer
Dae-Won Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status
Tsuyoshi Hamada et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Surveillance after curative treatment for colorectal cancer
Eric P. van der Stok et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Susan Bullman et al.
SCIENCE (2017)
Intratumoral Fusobacterium nucleatum abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma
Hye Eun Park et al.
VIRCHOWS ARCHIV (2017)
Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer A Systematic Review and Meta-analysis
Fausto Petrelli et al.
JAMA ONCOLOGY (2017)
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
TaChung Yu et al.
CELL (2017)
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Kosuke Mima et al.
GUT (2016)
Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location
Kosuke Mima et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
Chamutal Gur et al.
IMMUNITY (2015)
Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway
Miki Ito et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma
Kosuke Mima et al.
JAMA ONCOLOGY (2015)
Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma
Tomomitsu Tahara et al.
CANCER RESEARCH (2014)
Targeted Therapies in Metastatic Colorectal Cancer: A Systematic Review and Assessment of Currently Available Data
Martha M. Kirstein et al.
ONCOLOGIST (2014)
Effects of Antibiotics on Bacterial Species Composition and Metabolic Activities in Chemostats Containing Defined Populations of Human Gut Microorganisms
Dorothy F. Newton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
Mara Roxana Rubinstein et al.
CELL HOST & MICROBE (2013)
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Mauro Castellarin et al.
GENOME RESEARCH (2012)
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Aleksandar D. Kostic et al.
GENOME RESEARCH (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up
R. Labianca et al.
ANNALS OF ONCOLOGY (2010)
Is there a difference in survival between right- versus left-sided colon cancers?
Robert A. Meguid et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
A Grothey et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:: A randomized GERCOR study
C Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
分享论文
